DNA Panels Could Predict Endoscopic Response to Biologics in

Peripheral blood biomarkers in development that use DNA methylation could predict endoscopic response to treatment with adalimumab, vedolizumab, and ustekinumab for patients with Crohn's disease.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Netherlands , Denmark , Copenhagen , Køavn , Amsterdam , Noord Holland , Vincent Joustra , Tim Raine , Infinium Methylationepic Beadchip , Department Of Gastroenterology , Amsterdam University Medical Centers , Colitis Organisation , Cambridge University Hospitals , Oxford University , European Crohn , Harvey Bradshaw Index , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Crohns Disease , Methylation , Biomarker , Iological Marker , Biologic Therapy , Blood , Colitis , Epigenetics , Genomics , Genomic Medicine , Edicine Genomic , Clinical Research , Clinical Trials , Linical Studies , Corticosteroid , Europe , European , Fellowship , Yellows , Uk National Health Service , United Kingdom National Health Service , K Nhs , Dhs ,